• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ROCHE CARDIAC, TROPONIN T QUANTITATIVE; IMMUNOASSAY METHOD, TROPONIN SUBUNIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ROCHE CARDIAC, TROPONIN T QUANTITATIVE; IMMUNOASSAY METHOD, TROPONIN SUBUNIT Back to Search Results
Catalog Number ASKU
Device Problem False Alarm (1013)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/12/2015
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The customer reported that they received an erroneous alarm from their cobas h 232 analyzer when testing troponin t quantitative (tnt) on one patient sample.The customer stated that this is not the only occasion where this issue occurred, but provided no further information.The cobas h 232 analyzer is not sold in the united states, nor is it like or similar to a product sold in the united states.The date of the event was asked for, but not provided.The cobas h 232 analyzer alarmed that it detected an elevated tnt result during measurement of the sample.A nurse operating the analyzer was on the phone with the doctor and informed the doctor of the elevated tnt result alarm.When measurement of the sample was complete, it had a final result of below 50 ng/l.The patient was prescribed medication based on the elevated tnt alarm.It was asked, but it is not known if the patient was adversely affected due to receiving the prescription.No adverse events were alleged.The cobas h 232 analyzer serial number was (b)(4).
 
Manufacturer Narrative
It has been confirmed that the patient was treated with one aspirin in response to the high tnt alarm.The patient was hospitalized and has now been released from the hospital.The patient was provided litalgin iv and perfalgan in the ambulance prior to sample collection.The date of the event is (b)(6) 2015.Medwatch the date received by the manufacturer is (b)(4) 2015.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROCHE CARDIAC, TROPONIN T QUANTITATIVE
Type of Device
IMMUNOASSAY METHOD, TROPONIN SUBUNIT
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5261947
MDR Text Key32580233
Report Number1823260-2015-04657
Device Sequence Number1
Product Code MMI
Combination Product (y/n)N
Reporter Country CodeFI
PMA/PMN Number
K000784
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 12/03/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/02/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Event Location Laboratory
Date Manufacturer Received11/12/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-